Remove 2018 Remove Clinic Remove Individual Remove Management
article thumbnail

The utilization patterns and impact of the Stanford Chronic Pain Self-Management Program in Eastern Ontario, Canada [Pain management]

Annals of Family Medicine

One potential solution is to facilitate patient access to programs that develop skills and confidence in managing their own care. Population studied: The CPSMP targeted individuals suffering from chronic pain in the Champlain region of Eastern Ontario. The number of participants peaked in 2018 and remained stable thereafter.

article thumbnail

Comorbidities Influence Optic Outcomes in NMOSD

Physician's Weekly

The dataset, acquired between 2000 and 2018, comprised OCT and clinical metadata. The AQP4-NMOSD individuals with CVC/RF had higher ON relapse rates than those with AID (1.06 ± 3.33 Data was collected from 22 centers across North and South America, Asia, and Europe, following STROBE reporting guidelines.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Episode 148: Antiracism in Medicine Series Episode 4 – Dismantling Race-Based Medicine Part 2: Clinical Perspectives

The Clinical Problem Solvers

Nwamaka Eneanya and Jennifer Tsai to discuss the limitations and harms of race-based medicine in clinical practice. Our guests explain how we can incorporate race-conscious medicine in clinical settings, medical education, and biomedical/epidemiological research to responsibly recognize and address the harms of racial inequality.

Clinic 52
article thumbnail

Green Practice News: April 2025

My Green Doctor

from 2000 to 2018 among people over 65 years old. Heather Massey, Sustainability Programs Manager hmassey@mygreendoctor.org (469) 877-4608 Make the Pledge Today! It tells your office colleagues and patients that your healthcare practice or clinic is committed to forging a healthier work space and community. Contact us today!

article thumbnail

At Long Last, FDA Unveils Plan for Rare Disease Innovation Hub

FDA Law Blog

This individual will play a key role in overseeing the new integrated Hub model and helping to develop and implement its strategic agenda action plan. clinical pharmacology/biomarkers, animal models, real-world evidence and other externally controlled comparisons [e.g.,

article thumbnail

Caring for Patients with Duchenne Muscular Dystrophy in the Emergency Department: A Problem-Based Approach

PEMBlog

The condition affects multiple organ systems—muscular, cardiac, and respiratory—leading to a myriad of clinical complications. When patients with DMD present in the Emergency Department (ED), an understanding of the nuanced aspects of their care is essential for optimal management.

article thumbnail

District Court Interprets EKRA

FDA Law Blog

Wasserstein — “EKRA” refers to the Eliminating Kickbacks in Recovery Act, which was part of the Substance Use – Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018. EKRA is codified at 18 U.S.C. § 220 and was described on HP&M’s blog here. 18 U.S.C. § 18 U.S.C. § 220(e)(2).